Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Monoamine Oxidase. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105441401A reveals enzymatic route for HCV intermediates. Reduces heavy metal use and simplifies scale-up for reliable supply.
Patent CN114736882A discloses high-performance monoamine oxidase mutants for asymmetric oxidation, enabling cost reduction in API manufacturing and reliable supply.
Patent CN114736882B reveals high-efficiency biocatalysis for antiviral intermediates. Offers supply chain stability and cost reduction in API manufacturing without heavy metals.
Novel Penicillium-derived monoamine oxidase enables high-concentration biocatalysis for antiviral drug intermediates, ensuring supply chain stability and cost efficiency.